Ignite Creation Date:
2025-12-24 @ 9:29 PM
Ignite Modification Date:
2026-03-29 @ 10:33 AM
Study NCT ID:
NCT02095132
Status:
COMPLETED
Last Update Posted:
2023-09-26
First Post:
2014-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Central Nervous System Embryonal Tumor With Rhabdoid Features | View |
| None | Central Nervous System Embryonal Tumor, Not Otherwise Specified | View |
| None | Central Nervous System Ganglioneuroblastoma | View |
| None | Embryonal Tumor With Multilayered Rosettes, C19MC-Altered | View |
| None | Pineoblastoma | View |
| None | Primary Central Nervous System Neoplasm | View |
| None | Recurrent Childhood Central Nervous System Embryonal Neoplasm | View |
| None | Recurrent Malignant Solid Neoplasm | View |
| None | Recurrent Medulloblastoma | View |
| None | Recurrent Neuroblastoma | View |
| None | Recurrent Rhabdomyosarcoma | View |
| None | Refractory Malignant Solid Neoplasm | View |
| None | Refractory Medulloblastoma | View |
| None | Refractory Neuroblastoma | View |
| None | Refractory Rhabdomyosarcoma | View |
Keywords: